Isto Biologics
-
Biologics
Isto Biologics Unveils Fibrant Liberty™ An Advanced Allograft Solution Designed for Rapid and Consistent Hydration
The newest addition to the Fibrant product line HOPKINTON, Mass., May 8, 2024 (Newswire.com) – Isto Biologics, a global leader in…
Read More » -
Biologics
Advanced Biologics Elevates Biologic Innovations Through Merger with Isto Biologics
CARLSBAD, Calif., Oct. 18, 2023 /PRNewswire/ — Advanced Biologics (known commercially as Biologica Technologies), a California-based company known for their innovative biologic solutions, announced…
Read More » -
Biologics
Isto Biologics Launches Influx™ Fibrant, a New Line of Advanced Allograft
HOPKINTON, Mass., June 22, 2022 (Newswire.com) – Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today the…
Read More » -
Biologics
Isto Biologics acquires TheraCell, adding additional novel products to help patients heal faster
The acquisition of TheraCell, Inc. will expand access for two best-in-class product portfolios and build upon Isto’s continued commitment to…
Read More » -
Biologics
Isto Biologics Introduces New Influx DBM Putty
HOPKINTON, Mass. – September 5, 2019 – (Newswire.com) Isto Biologics, an orthobiologics company dedicated to improving patient quality of life,…
Read More » -
Biologics
Isto and Arteriocyte join forces to form leading biologics player, Isto Biologics
ST. LOUIS, Oct. 19, 2016 /PRNewswire/ — Isto Holdings, the parent company of St. Louis-based Isto Technologies – a leader in bone-regeneration technologies and…
Read More »